Filter
375
Filtered Results: 375
Text search:
M.
Muñoz
Featured
Recommendations
34
New Publications
52
Language
Document type
No document type
169
Studies & Reports
85
Guidelines
70
Manuals
25
Strategic & Response Plan
10
Fact sheets
9
Training Material
3
Situation Updates
2
Brochures
1
Infographics
1
Countries / Regions
Latin America and the Carribbean
30
Colombia
15
Western and Central Europe
13
Chile
12
Kenya
10
Global
10
Russia
10
Germany
9
Rwanda
7
Eastern Europe
7
Brazil
7
Ecuador
7
Ukraine
6
Venezuela
6
Paraguay
6
India
6
Middle East and North Africa
5
South Africa
5
Malawi
4
Mozambique
4
Africa
4
Syria
3
Tanzania
3
Spain
3
Argentina
3
Ethiopia
3
Nepal
2
Nigeria
2
Zimbabwe
2
Philippines
2
USA
2
Asia
2
South–East Asia Region
2
North America
2
East and Southern Africa
2
Liberia
2
Thailand
1
El Salvador
1
Turkey
1
Ghana
1
Sierra Leone
1
China
1
Canada
1
Singapore
1
Senegal
1
Peru
1
Malaysia
1
West and Central Africa
1
Japan
1
Portugal
1
Bolivia
1
Bangladesh
1
Vietnam
1
Moldova
1
Yemen
1
Mali
1
Angola
1
Botswana
1
South Sudan
1
Indonesia
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
129
Clinical Guidelines
54
Public Health
16
Women & Child Health
15
Key Resources
6
Capacity Building
3
Pharmacy & Technologies
3
Toolboxes
Mental Health
56
COVID-19
52
TB
42
NTDs
28
HIV
21
Refugee
13
Planetary Health
13
Disability
10
Rapid Response
9
NCDs
6
Global Health Education
6
Ebola
5
Caregiver
5
AMR
5
Zika
4
Pharmacy
3
Specific Hazards
1
Cholera
1
Social Ethics
1
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. This publication addresses medical devices for six types of cancer: breast, cervical, colorectal, leukem...
13 July 2021
The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both pass...
Las Infecciones Asociadas a la Atención en Salud (IAAS) son reconocidas en la
actualidad como un problema de salud pública y existen lineamientos guber-
namentales en la mayoría de los países para constituir sistemas de vigilancia y
Programas de Prevención y Control de Infecciones para con...
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
Human use of land has been transforming Earth's ecology for millennia. From hunting and foraging to burning the land to farming to industrial agriculture, increasingly intensive human use of land has reshaped global patterns of biodiversity, ecosystems, landscapes, and climate. This review examines ...
Screening programmes for tuberculosis (TB) among immigrants rarely consider the heterogeneity of
risk related to migrants’ country of origin. We assess the performance of a large screening programme in asylum seekers by analysing (i) the difference in yield and numbers needed to screen (NNS) by c...
Surveillance Report
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
The ninth WHO report on the global tobacco epidemic tracks the progress made by countries in tobacco control since 2008 and, marks 15 years since the introduction of the MPOWER technical package which is designed to help countries implement the demand-reduction measures of the WHO Framework Conventi...
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
La carga de la diabetes es enorme, posicionándola como uno de los principales desafíos que enfrenta la salud pública en la actualidad. Actualmente, se estima que 62 millones de personas viven con diabetes en la Región de las Américas y las proyecciones muestran que su prevalencia seguirá aumen...
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
Key questions
What is already known?
Critical illness is common throughout the world and COVID-19 has caused a global surge of critically ill patients.
There are large gaps in the quality of care for critically ill patients, especially in low-staffed and low-resourced settings, and mortal...
